Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.

Jin S, Fu S, Han J, Jin S, Lv Q, Lu Y, Qi J, Wu W, Yuan H.

J Drug Target. 2012 Aug;20(7):615-22. doi: 10.3109/1061186X.2012.702770.

PMID:
22726209
2.

Mixed nanomicelles loaded with thymopeptides-sodium deoxycholate/phospholipid improve drug absorption.

Shi-Xiao J, Shi-Ying J, Lv QY, Shan-Shan F, Jin H, Yuan HL.

Chin J Nat Med. 2014 Jan;12(1):65-70. doi: 10.1016/S1875-5364(14)60011-X.

PMID:
24484599
3.

Application of spray granulation for conversion of mixed phospholipid-bile salt micelles to dry powder form: influence of drug hydrophobicity on nanoparticle reagglomeration.

Lv Q, Li X, Shen B, Xu H, Shen C, Dai L, Bai J, Yuan H, Han J.

Int J Nanomedicine. 2014 Jan 15;9:505-15. doi: 10.2147/IJN.S56215.

4.

Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating.

Dong F, Xie Y, Qi J, Hu F, Lu Y, Li S, Wu W.

Int J Nanomedicine. 2013;8:1653-63. doi: 10.2147/IJN.S42349.

5.
6.

Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats.

Sasaki K, Yonebayashi S, Yoshida M, Shimizu K, Aotsuka T, Takayama K.

Int J Pharm. 2003 Oct 20;265(1-2):95-102.

PMID:
14522122
7.

Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.

Guan P, Lu Y, Qi J, Niu M, Lian R, Hu F, Wu W.

Int J Nanomedicine. 2011;6:965-74. doi: 10.2147/IJN.S19259.

8.

[Rat intestine absorption kinetics study on cucurbitacin B-sodium deoxycholate/phospholipid mixed nanomicelles with in vitro everted gut sacs model].

Cheng L, Shen BD, Li JJ, Qiu L, Shen G, Zhang LH, Han J, Yuan HL.

Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(14):2876-81. Chinese.

PMID:
26666043
9.

[Preparation and characterization of cucurbitacin B sodium deoxycholate/phospholipid-mixed oral fast dissolving film and antitumor activity study].

Yu C, Xiao YZ, Xun PH, Dai L, Han J, Yuan HL.

Zhongguo Zhong Yao Za Zhi. 2014 May;39(10):1799-804. Chinese.

PMID:
25282885
10.

Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.

Duan Y, Wang J, Yang X, Du H, Xi Y, Zhai G.

Drug Deliv. 2015 Jan;22(1):50-7. doi: 10.3109/10717544.2013.873501.

PMID:
24417664
11.

In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats.

Kimura M, Moro T, Motegi H, Maruyama H, Sekine M, Okamoto H, Inoue H, Sato T, Ogihara M.

Eur J Pharmacol. 2008 Jan 28;579(1-3):357-64.

PMID:
18022618
12.

[Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride].

Li Y, Li Y, Liu GT.

Zhonghua Yi Xue Za Zhi. 2004 Dec 17;84(24):2096-101. Chinese.

PMID:
15730626
13.

Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.

Niu M, Lu Y, Hovgaard L, Guan P, Tan Y, Lian R, Qi J, Wu W.

Eur J Pharm Biopharm. 2012 Jun;81(2):265-72. doi: 10.1016/j.ejpb.2012.02.009.

PMID:
22369880
14.

Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for Cucurbitacin B delivery.

Lv Q, Shen C, Li X, Shen B, Yu C, Xu P, Xu H, Han J, Yuan H.

Drug Deliv. 2015 May;22(3):351-8. doi: 10.3109/10717544.2013.876459.

PMID:
24467528
15.

A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo.

Xia HJ, Zhang ZH, Jin X, Hu Q, Chen XY, Jia XB.

Int J Nanomedicine. 2013;8:545-54. doi: 10.2147/IJN.S39526.

16.

Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis.

Abe M, Akbar F, Hasebe A, Horiike N, Onji M.

J Gastroenterol. 2003;38(10):962-7.

PMID:
14614603
17.

Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.

Guo JJ, Yue PF, Lv JL, Han J, Fu SS, Jin SX, Jin SY, Yuan HL.

Int J Pharm. 2013 Jan 30;441(1-2):227-33. doi: 10.1016/j.ijpharm.2012.11.039.

PMID:
23220096
18.

Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.

Makino T, Ohtake N, Watanabe A, Tsuchiya N, Imamura S, Iizuka S, Inoue M, Mizukami H.

Drug Metab Dispos. 2008 Jul;36(7):1438-43. doi: 10.1124/dmd.108.021089.

19.

[The absorption features of glycyrrhizic acid in composition of drug "phosphogliv"].

Voskresenskaia AA, Medvedeva NV, Prozorovskiń≠ VN, Moskaleva NE, Ipatova OM.

Biomed Khim. 2012 Sep-Oct;58(5):564-72. Russian.

PMID:
23289298
20.

Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.

Ao Y, Chen J, Yue J, Peng RX.

Eur J Pharmacol. 2008 Jun 10;587(1-3):330-5. doi: 10.1016/j.ejphar.2008.03.043.

PMID:
18462715
Items per page

Supplemental Content

Support Center